title: Management of postblepharoplasty lower eyelid retraction.
abstract: Future advances in the treatment of lower eyelid retraction will likely focus on new synthetic graft materials that are inert and stable with minimal potential for reabsorption. Other advances may focus on biomodulating agents that reduce the risk of retraction at the time of cosmetic eyelid surgery or reverse existing exuberant scarring. Nonsurgical options are viable for modest cases, and these conservative measures may continue to improve, but, for severe retraction, surgery still offers the best promise of correction.
authors.affiliation: Private Practice, New York, New York, USA.
authors.forename: Brett
authors.initials: B
authors.lastname: Kotlus
authors.affiliation: Oculofacial Plastic & Reconstructive Surgery, Ophthalmology, Montefiore Medical Center, Albert Einstein College of Medicine, 135 East 71st Street, New York, NY 10021, USA. Electronic address: rschwarcz@gmail.com.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Schwarcz
mesh_terms: D019882:Blepharoplasty / Q000009:adverse effects*; D005143:Eyelids / Q000033:anatomy & histology / Q000601:surgery*; D006801:Humans
keywords: Blepharoplasty; Eyelid retraction; Facial rejuvenation; Oculoplasty; Surgical procedures